| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |